Insider Purchases Signal Confidence at Rallybio Amid Strategic Shifts and Clinical Progress
Adar1 Capital Management, LLC, along with its sole manager Daniel Schneeberger, recently purchased a substantial number of Rallybio Corp (NASDAQ:RLYB) common shares. These insider transactions occurred in May 2026 and come against a backdrop of mixed company news, including the termination of a planned merger but also positive Phase 1 clinical resu…